Get the Stockscreener App
0.00
100.00%
-0.8441
Mainz Biomed N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$0.8441
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$10.56M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
0.00
EPS:
-65.5728
Net Cash Flow:
$-23.84M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$2.17
Mainz Biomed N V Stock (MYNZ) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare MYNZ vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
525.72 | 197.88B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.90 | 144.26B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.18 | 44.76B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
265.06 | 38.87B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.67 | 37.13B | 7.23B | 1.41B | 1.09B | 4.979 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (MYNZ) Latest News
Mainz Biomed (MYNZ) 10K Form and Latest SEC Filings 2026 - MarketBeat
Mainz Biomed NV (MYNZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed (QUCY) Q4 2023 Earnings: EPS Surpasses Estimates as Company Advances Clinical ProgramsAnalyst Consensus Shift - dars.gov.et
Mainz Biomed N V Ord Shs (QUCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed NV (MYNZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed NV (MYNZ) Institutional Confidence - TradingKey
Mainz Biomed NV (MYNZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Institutional Confidence - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed NV (MYNZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mainz Biomed NV (MYNZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mainz Biomed BV (NASDAQ: MYNZ) Share Price, MYNZ Stock News, MYNZ Share Price & Updates - Kalkine
Mainz Biomed Q4 2023 Earnings: EPS Beats Estimates Despite No Reported RevenueProfit Inflection Point - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beats Expectations Amid Operational ChallengesProfit Guidance Range - newsline.com
[8-K] Quantum Cyber N.V. Reports Material Event - Stock Titan
Mainz Biomed (QUCY) Q4 2023 Earnings: Narrowed Loss Beats Estimates, Stock RalliesNegative Surprise Momentum - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beat Amid Revenue Uncertainty, Stock Declines 14%Earnings Surprise Report - newsline.com
Quantum Cyber (NASDAQ: MYNZ) restores Nasdaq minimum bid rule compliance - Stock Titan
QUCYQuantum Cyber NV Stock Price and Quote - Finviz
Director Ben-Tzvi Avraham granted 137,141 Quantum Cyber (MYNZ) shares - Stock Titan
Quantum Cyber (Nasdaq: QUCY) raises $15M and wipes out all debt - Stock Titan
Mainz Biomed (QUCY) Slides 6.5% as Stock Tests Key Support ZoneBreakaway Gap - The Legal Advocate
Mainz Biomed N.V. Ordinary Shares Q4 2023 Earnings: EPS Beat Estimate Despite Absence of Revenue, Stock DeclinesEnergy Earnings Report - Newser
From Cancer Tests to Combat Drones: Mainz Biomed's Radical Reinvention Nears a Key Vote - AD HOC NEWS
Mainz Biomed’s Big Pivot: New Name, New Risks, Same Volatility - Finimize
Quantum Cyber's Patent Salvo Drives Stock Rally Amid Insider Share Awards and Cash Concerns - AD HOC NEWS
Guido Baechler files Form 144 to sell 200,000 MYNZ shares (MYNZ) - Stock Titan
Quantum Cyber N.V. and Other Players Eye Potential CHIPS Act Funding From Trump Administration - The Globe and Mail
Quantum Cyber (QUCY) director files Form 3 reporting zero ordinary shares - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) director awarded 137,141 ordinary shares in Form 4 filing - Stock Titan
QUCY Stock Price and Chart — NASDAQ:QUCY - TradingView
Quantum Cyber forms US defense subsidiary for drone programs - MSN
QUCY Stock Price, Quote & Chart | QUANTUM CYBER NV (NASDAQ:QUCY) - ChartMill
[144] Quantum Cyber N.V. SEC Filing - Stock Titan
Quantum Cyber (MYNZ) inks exclusive IP license with $5M cash and shares - Stock Titan
Mainz Biomed N.v. Live Share Prices and Trades. QUCY.US Live Streaming Share Prices. - London South East
[10-Q] Quantum Cyber N.V. Quarterly Earnings Report - Stock Titan
Quantum Cyber site spotlights drones as Trump administration seeks $55B - Stock Titan
Quantum Cyber N.V. (QUCY-Q) Stock Price and News - The Globe and Mail
3 Penny Stocks to Watch Now, 5/14/26 - TipRanks
Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus - TechStock²
Quantum Cyber appoints former VA acting secretary to board - Investing.com India
Mainz Biomed Stock Surges 315% as QUCY Hits $1.34 on Massive Volume - Meyka
Mainz Biomed N V Stock (MYNZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):